• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与菊粉-壳聚糖佐剂结合显著提高结核分枝杆菌CFP10-TB10.4融合蛋白的免疫原性。

Conjugation with an Inulin-Chitosan Adjuvant Markedly Improves the Immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 Fusion Protein.

作者信息

Yu Weili, Hu Tao

机构信息

State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences , Beijing 100190, China.

University of Chinese Academy of Sciences , Beijing 100190, China.

出版信息

Mol Pharm. 2016 Nov 7;13(11):3626-3635. doi: 10.1021/acs.molpharmaceut.6b00138. Epub 2016 Oct 18.

DOI:10.1021/acs.molpharmaceut.6b00138
PMID:27723352
Abstract

Protein-based vaccines are of potential to deal with the severe situations posed by Mycobacterium tuberculosis (Mtb). Due to inherently poor immunogenicity of Mtb protein antigens, a potent immunostimulatory adjuvant is needed to enhance the cellular and humoral immune response to Mtb protein antigens. Inulin and chitosan (Cs) are polysaccharide adjuvants that can be used to achieve such an objective. The inulin-Cs conjugate (inulin-Cs) acted as a potent adjuvant through a synergistic interaction of inulin and Cs. CFP10 and TB10.4 are two important virulent protein antigens of Mtb. The CFP10-TB10.4 fusion protein (CT) was constructed and used as the protein antigen. In the present study, an adjuvant delivery system (inulin-Cs-CT) was developed by covalent conjugation of CT with inulin-Cs. Conjugation with inulin-Cs significantly increased the hydrodynamic volume of CT and did not alter the structure of CT. High levels of Th1-type cytokines (IFN-γ, TNF-α, and IL-2) and Th2-type cytokine (IL-4) were secreted by provocation of inulin-Cs-CT. Inulin-Cs-CT elicited high CT-specific antibody titers, mostly in the form of IgG1 and IgG2b. Pharmacokinetics revealed that conjugation with inulin-Cs could prolong the serum exposure of CT to the immune system. Pharmacodynamics suggested that conjugation with inulin-Cs led to an efficient production of CT-specific IgG. Thus, conjugation of inulin-Cs can serve as a potent adjuvant delivery system to improve the immunogenicity of the Mtb protein antigens.

摘要

基于蛋白质的疫苗有潜力应对由结核分枝杆菌(Mtb)引发的严峻形势。由于Mtb蛋白质抗原固有的免疫原性较差,因此需要一种有效的免疫刺激佐剂来增强对Mtb蛋白质抗原的细胞免疫和体液免疫反应。菊粉和壳聚糖(Cs)是可用于实现这一目标的多糖佐剂。菊粉-壳聚糖共轭物(菊粉-Cs)通过菊粉和Cs的协同相互作用作为一种有效的佐剂。CFP10和TB10.4是Mtb的两种重要的毒力蛋白抗原。构建了CFP10-TB10.4融合蛋白(CT)并将其用作蛋白质抗原。在本研究中,通过CT与菊粉-Cs的共价共轭开发了一种佐剂递送系统(菊粉-Cs-CT)。与菊粉-Cs共轭显著增加了CT的流体动力学体积,并且没有改变CT的结构。通过刺激菊粉-Cs-CT分泌了高水平的Th1型细胞因子(IFN-γ、TNF-α和IL-2)和Th2型细胞因子(IL-4)。菊粉-Cs-CT引发了高CT特异性抗体滴度,主要以IgG1和IgG2b的形式存在。药代动力学表明,与菊粉-Cs共轭可以延长CT在免疫系统中的血清暴露时间。药效学表明,与菊粉-Cs共轭导致CT特异性IgG的有效产生。因此,菊粉-Cs共轭可以作为一种有效的佐剂递送系统来提高Mtb蛋白质抗原的免疫原性。

相似文献

1
Conjugation with an Inulin-Chitosan Adjuvant Markedly Improves the Immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 Fusion Protein.与菊粉-壳聚糖佐剂结合显著提高结核分枝杆菌CFP10-TB10.4融合蛋白的免疫原性。
Mol Pharm. 2016 Nov 7;13(11):3626-3635. doi: 10.1021/acs.molpharmaceut.6b00138. Epub 2016 Oct 18.
2
Conjugation of the CRM-inulin conjugate significantly increases the immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 fusion protein.CRM-菊粉缀合物的缀合显著提高了结核分枝杆菌CFP10-TB10.4融合蛋白的免疫原性。
Bioorg Med Chem. 2017 Nov 1;25(21):5968-5974. doi: 10.1016/j.bmc.2017.09.027. Epub 2017 Sep 19.
3
Conjugation Reaction with 8-Arm PEG Markedly Improves the Immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 Fusion Protein.与八臂聚乙二醇的缀合反应显著提高了结核分枝杆菌CFP10-TB10.4融合蛋白的免疫原性。
Bioconjug Chem. 2017 Jun 21;28(6):1658-1668. doi: 10.1021/acs.bioconjchem.7b00131. Epub 2017 May 26.
4
Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.表达 ESAT6-CFP10 融合蛋白的重组耻垢分枝杆菌诱导抗分枝杆菌免疫应答,并保护小鼠免受结核分枝杆菌攻击。
Scand J Immunol. 2010 Oct;72(4):349-57. doi: 10.1111/j.1365-3083.2010.02448.x.
5
Conjugation with loxoribine and mannan improves the immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 fusion protein.洛索核糖与甘露聚糖缀合可提高结核分枝杆菌 CFP10-TB10.4 融合蛋白的免疫原性。
Eur J Pharm Biopharm. 2022 Mar;172:193-202. doi: 10.1016/j.ejpb.2022.02.011. Epub 2022 Feb 18.
6
Potent Antigen-Adjuvant Delivery System by Conjugation of Mycobacterium tuberculosis Ag85B-HspX Fusion Protein with Arabinogalactan-Poly(I:C) Conjugate.通过结核分枝杆菌Ag85B-HspX融合蛋白与阿拉伯半乳聚糖-聚(I:C)缀合物的缀合构建高效抗原佐剂递送系统。
Bioconjug Chem. 2016 Apr 20;27(4):1165-74. doi: 10.1021/acs.bioconjchem.6b00116. Epub 2016 Mar 30.
7
[Immune response and protective efficacy induced by fusion protein ESAT6-CFP10 of M.tuberculosis in mice].[结核分枝杆菌融合蛋白ESAT6-CFP10在小鼠体内诱导的免疫反应及保护效果]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Jul;22(4):443-6.
8
Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.壳聚糖微球增强了一种基于Ag85B的融合蛋白的免疫原性,该融合蛋白包含结核分枝杆菌的多个T细胞表位。
Eur J Pharm Biopharm. 2007 Jun;66(3):318-26. doi: 10.1016/j.ejpb.2006.11.028. Epub 2007 Jan 12.
9
Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of four protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection.Advax4 佐剂与 delta 菊粉联合应用,以及 ECMX,即四种保护性结核分枝杆菌抗原的融合构建体,可诱导强烈的 Th1 免疫应答,并保护小鼠免受结核分枝杆菌感染。
Hum Vaccin Immunother. 2017 Dec 2;13(12):2967-2976. doi: 10.1080/21645515.2017.1368598.
10
A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.一种表达结核分枝杆菌CFP10、ESAT6、Ag85A和Ag85B的重组腺病毒在小鼠中引发强烈的抗原特异性免疫反应。
Mol Immunol. 2014 Nov;62(1):86-95. doi: 10.1016/j.molimm.2014.06.007. Epub 2014 Jun 28.

引用本文的文献

1
Chitosan non-particulate vaccine delivery systems.壳聚糖非微粒疫苗递送系统
J Pharm Pharm Sci. 2024 Jul 24;27:12921. doi: 10.3389/jpps.2024.12921. eCollection 2024.
2
The Use of Particulate Systems for Tuberculosis Prophylaxis and Treatment: Opportunities and Challenges.颗粒系统在结核病预防和治疗中的应用:机遇与挑战
Microorganisms. 2023 Aug 2;11(8):1988. doi: 10.3390/microorganisms11081988.
3
A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice.
一种新型的靶向C型凝集素受体的基于α-突触核蛋白的帕金森疫苗在小鼠中诱导出强效免疫反应和治疗效果。
Vaccines (Basel). 2022 Aug 30;10(9):1432. doi: 10.3390/vaccines10091432.
4
Conjugation with 8-arm PEG and CRM enhances the immunogenicity of SARS-CoV-2 ORF8 protein.与 8 臂聚乙二醇(PEG)和 CRM 缀合可增强 SARS-CoV-2 ORF8 蛋白的免疫原性。
Int Immunopharmacol. 2022 Aug;109:108922. doi: 10.1016/j.intimp.2022.108922. Epub 2022 Jun 6.
5
Peptide-Based Vaccines for Tuberculosis.基于肽的结核病疫苗。
Front Immunol. 2022 Jan 31;13:830497. doi: 10.3389/fimmu.2022.830497. eCollection 2022.
6
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants.开发新型抗结核疫苗:聚焦佐剂。
Cells. 2021 Jan 5;10(1):78. doi: 10.3390/cells10010078.
7
The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity.肺炎球菌多糖-破伤风类毒素天然 C 片段缀合疫苗:载体效应和免疫原性。
Mediators Inflamm. 2020 Jul 4;2020:9596129. doi: 10.1155/2020/9596129. eCollection 2020.
8
Novel application of trimethyl chitosan as an adjuvant in vaccine delivery.三甲基壳聚糖作为佐剂在疫苗传递中的新应用。
Int J Nanomedicine. 2018 Nov 23;13:7959-7970. doi: 10.2147/IJN.S165876. eCollection 2018.
9
Anti-cancer efficacy of biotinylated chitosan nanoparticles in liver cancer.生物素化壳聚糖纳米颗粒在肝癌中的抗癌疗效
Oncotarget. 2017 Jul 10;8(35):59068-59085. doi: 10.18632/oncotarget.19146. eCollection 2017 Aug 29.